Generic Pharmaceutical Business Investment Opportunities

Revenue model: Margin from products. - Team: Led by industry veterans. - Customers: 120+ premium B2B customers. - Running successfully for the last 5 plus years with steady growth. - 40% of the revenue is generated by selling medical equipment and 60% is generated by selling medicines. - We work with healthcare non-profits to strengthen the health of their organization, helping them control costs, develop efficiencies and enhance quality. - We act as a centralized sourcing and distributing partner focused on servicing medical product needs for medical organizations. - The business possesses Drug, PCPNDT, food and export licenses. - The revenue has significantly increased this year since we have onboarded new customers.

The company has developed remedies for headache, hangover, and migraine, positioning itself as an innovator in the market. - Manufactured and sold under its own brand name. - Currently, in the "soft" launch phase in 100 locations nationwide, the company is selling through a distribution network to pharma retail outlets such as CVS and Walmart. - The business is experiencing a high level of satisfaction and repeat buyers, indicating a strong market response to its products. - With established relationships and a sales team, the company aims to expand to hundreds of thousands of locations nationally, with a focus on e-commerce due to high margins and a product that aligns well with the subscription model for consistent repeat sales. - With over 16 years of experience in the pharma industry, the company has expertise in running a successful subscription business model, positioning it for long-term success. - The product is registered as a dietary supplement under the FDA. - There are 11 permanent employees who are necessary for running the business operations, employed in production, admin, management, sales & marketing sectors.

Distributors for pharmaceutical companies. - Top-selling human albumin and retina products. - Supply to hospitals, government, and corporate customers like ASG and Sharp Sight. - Major revenue from hospitals in Varanasi and peripheral areas. - 14 years of experience in the retina and plasma-derived products like albumin, IVIG, HBIG, and HRIG. - The drug is used in treating ICU and kidney patients. - Promoters have 20 years of experience in the industry. - Purchase goods at cost from pharmaceutical companies. - Exclusive territorial rights in Varanasi for selling goods. - Partnerships with 60 hospitals and clinics. - Licensed with GST, drug, and FSSAI certifications. - Since we are highly efficient in our operations, we have a low employee count and a lean business model.

Specialize in OEM manufacturing for diabetic medicines catering to hospitals and research institutions. - Established client base includes Malaysian royalty and export to the lucrative China market. - Profitable operations with plans for expansion. - Conducted clinical trials in collaboration with NUH (National University Hospital) for diabetic treatments. - Collaborative research and development projects with NYP (Nanyang Polytechnic) for the Chinese market. - Multiple ongoing projects in the pipeline for further product development. - Diverse client base spanning healthcare and research institutions, totaling 300 in China alone. - Manufacturing capacity capable of producing 500 bottles/day of diabetic medications. - Bringing 10 years of industry experience to the table. - Fully licensed and compliant with ISO standards, with additional certifications including incorporation, factory license, and halal certification. - Proposal received from a Singapore hospital for a diabetic drug formulated with our curcumin. - Ready-to-drink beauty and wellness beverage featuring our curcumin, developed in collaboration with a local university as an alternative to energy drinks.

The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company. - They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months. - The facility was inspected very recently by the FDA and passed. - We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors. - The company should be worth USD 2B in another 3 years. - The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.

Pharma marketing company and virtual manufacturer of nutraceuticals and generic pharma medicines. - Have 21 brands registered under our own name along with their trademarks. - Third-party manufacturing, all our products are WHO and GMP certified. - Mostly on-ground sales work where we visit hospitals, clinics, and onboard doctors to prescribe our products. - We have more than 50 doctors as our prescribers. - Strong distributor network in Delhi NCR, we have around 5 distributors. - Payment terms are negotiated with each client. - Business loan of INR 5 lakh is being repaid at the moment. - Two owners with equal shareholding. - Business had reached a pre-Covid revenue of INR 72 lakh. The company had exponential growth in the pre-Covid years. - Covid affected operations as we could not deploy our sales team to visit hospitals and clinics. - We are a fast-paced organization and wish to get this funding by the end of this financial year.

Our pharma company is recognized by Global Vegetarian, a Halal-certified company that also has brands registered in Kenya. - We get our products manufactured from a third party under our own brand name. - Product promotion and sales are done with the help of tie-ups with the doctors and currently, we have tie-ups with more than 50 doctors for the same. - Our revenue is increasing gradually with the recognition of the brand in the market. - The company is completely liabilities-free and is solely owned by the user only.

Company manufactures generic pharmaceuticals for leading pharmaceutical companies. - Has more than 20 clients across Asia, Middle East, Africa and America. - Manufacturing capacity is 90,000 capsules per hour with latest equipment. Detailed capacities can be shared with interested parties upon introduction. - Company is established with an objective to provide unique product propositions which meets the customer requirements and expectations. - The unit is located at strategic location considering Gujarat a hub of various pharma giants. The existing manufacturing facility is equipped with latest technology for supreme manufacturing arrangement. - It has all valid license in terms of sales and export and approvals from WHO and FDA. - Company is a member of Pharmexcil (India) and Anti Microbial Resistance Industry Alliance (Switzerland). - The high growth in sales compared to last year is due to various factors including better economic situation with respect to the pandemic, increase number of approvals, capacity and clients. - Valuation is based on rapid growth rate and approvals. Company has applied for the European market approval which will open a door to new markets and client base. Company has the capacity to cater higher demands and requirements.

Nepal 1st Hormone and steroids based Pharmaceutical Company. -Hormones and steroids-based company with cleanroom, GMP certification, high tech equipment and a dedicated area for quality checks and innovation. - Fully Equipped for all Dosage form Solid and semisolid (Tablets, Capsule, ointment, liquid, cream, syrup soon on) - Major focused on innovation and creative drugs formulation and development. - We produce hormone medicines, generic tablets, liquids, ointments, capsules under our own brand name. - Have an in-house R&D department, quality control and quality assurance departments. - Currently have 14 hormone drugs and 18 general drugs and 60 new medicines are in the pipeline. - Business has over 55 distributors and super stockists who supply our drugs to doctors across Nepal. - We have enough production capacity to start exporting our medicines. - Huge Facility to start new project and plan. - Business is at the introductory phase of Product Life, with a better future perspective. - Facility is located in a safe place undisturbed with the residential area with good infrastructure and facilities. -Currently bearing losses due to first innovative products i. e. hormone manufacturers, facing many challenges from marketing and COVID pandemic crisis. - Secure future with innovative products in line along with huge production capacity and expansion possibilities. - The sales increased this year to ramping up of production and marketing efforts. The increase in revenue has taken our business to a break even point. We expect to be profitable in the upcoming year.